Ocular and central nervous system lymphoma:: clinical features and diagnosis

被引:152
作者
Cassoux, N
Merle-Beral, H
Leblond, V
Bodaghi, B
Miléa, D
Gerber, S
Fardeau, C
Reux, I
Xuan, KH
Chan, CC
LeHoang, P
机构
[1] Hop La Pitie Salpetriere, Dept Ophthalmol, F-75651 Paris 13, France
[2] Hop La Pitie Salpetriere, Dept Hematol, F-75651 Paris, France
[3] Hop La Pitie Salpetriere, Dept Neuroradiol, F-75651 Paris 13, France
[4] Hop La Pitie Salpetriere, Dept Neurol, F-75651 Paris 13, France
[5] NIH, Dept Immunol, Bethesda, MD 20892 USA
关键词
ocular lymphoma; cerebral lymphoma; diagnostic vitrectomy; PCR; chemotherapy;
D O I
10.1076/ocii.8.4.243.6463
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the clinical, angiographic, and cytopathologic features of ocular and central nervous system (CNS) lymphoma. Patients and methods: Retrospective study of 44 patients over a 10-year period. Results: A total of 36 women and six men, mean age 54 years (range: 36-90 years), were included. The mean time interval between onset of ocular symptoms and diagnosis was 40 months (range: 1-144 months). Ocular involvement was bilateral in 84% of the cases. Laser flare photometry readings averaged 9.6 photons/ms (2.9-78.3 photons/ms). Vitritis was constant. Funduscopy revealed RPE abnormalities in 60.49% of the cases and punctuate retinal infiltrates in 33.5%. The most common findings with fluorescein angiography were window defects and hypofluorescent round lesions. Patients had CNS involvement in 66% of the cases. Cytologic examination of the vitreous samples showed high-grade B lymphoma in 86% of the cases. Interleukin-10 dosage, when performed, showed elevated levels averaging 2352 pg/ml in all vitreous samples. Molecular biology based on PCR confirmed the diagnosis in 12 patients. Treatment included systemic chemotherapy alone or associated with radiotherapy in various regimens. Fourteen patients died during follow-up. Only 12 patients were in complete remission. Conclusion: The prognosis of the disease remains poor. However, the new diagnostic tools and therapeutic strategies may improve the diagnostic delay and the survival outcome.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 37 条
[1]   Intraocular-central nervous system lymphoma - Clinical features, diagnosis, and outcomes [J].
Akpek, EK ;
Ahmed, I ;
Hochberg, FH ;
Soheilian, M ;
Dryja, TP ;
Jakobiec, FA ;
Foster, CS .
OPHTHALMOLOGY, 1999, 106 (09) :1805-1810
[2]  
BAUMANN MA, 1986, CANCER, V57, P1273, DOI 10.1002/1097-0142(19860401)57:7<1273::AID-CNCR2820570702>3.0.CO
[3]  
2-C
[4]   INTERLEUKIN-10 IN THE VITREOUS OF PATIENTS WITH PRIMARY INTRAOCULAR LYMPHOMA [J].
CHAN, CC ;
WHITCUP, SM ;
SOLOMON, D ;
NUSSENBLATT, RB .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 120 (05) :671-673
[5]   Detection of molecular changes in primary intraocular lymphoma by microdissection and polymerase chain reaction [J].
Chan, CC ;
Shen, DF ;
Nussenblatt, RB ;
Boni, R ;
Zhuang, ZP .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1998, 7 (01) :63-64
[6]  
CHAR DH, 1988, OPHTHALMOLOGY, V95, P625
[7]   MALIGNANT LYMPHOMA OF THE UVEAL TRACT [J].
COOPER, EL ;
RIKER, JL .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1951, 34 (08) :1153-1158
[8]  
Corn BW, 1997, CANCER, V79, P2409
[9]   Diagnosis of intraocular lymphoma by flow cytometry [J].
Davis, JL ;
Viciana, AL ;
Ruiz, P .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (03) :362-372
[10]  
DAVIS JL, 1992, OPHTHALMOLOGY, V99, P250